- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 428726, 8 pages
Comparison of Explant-Derived and Enzymatic Digestion-Derived MSCs and the Growth Factors from Wharton’s Jelly
1Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul 110-744, Republic of Korea
2Department of Laboratory Medicine, Seoul National University Boramae Hospital, 425 Shindaebang-dong, Dongjak-gu, Seoul 156-707, Republic of Korea
3Seoul Metropolitan Public Cord Blood Bank, Allcord, Seoul 156-707, Republic of Korea
4Department of Pediatrics, Seoul National University Boramae Hospital, Seoul 156-707, Republic of Korea
5Department of Obstetrics and Gynecology, Seoul National University Boramae Hospital, Seoul 156-707, Republic of Korea
Received 7 November 2012; Revised 12 February 2013; Accepted 1 March 2013
Academic Editor: Richard Tucker
Copyright © 2013 Jong Hyun Yoon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. I. Caplan and J. E. Dennis, “Mesenchymal stem cells as trophic mediators,” Journal of Cellular Biochemistry, vol. 98, no. 5, pp. 1076–1084, 2006.
- G. Li, X.-A. Zhang, H. Wang et al., “Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration,” Proteomics, vol. 9, no. 1, pp. 20–30, 2009.
- K. C. Chao, K. F. Chao, Y. S. Fu, and S. H. Liu, “Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes,” PLoS ONE, vol. 3, no. 1, Article ID e1451, 2008.
- M. L. Weiss, S. Medicetty, A. R. Bledsoe et al., “Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease,” Stem Cells, vol. 24, no. 3, pp. 781–792, 2006.
- F. Alviano, V. Fossati, C. Marchionni, et al., “Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro,” BMC Developmental Biology, vol. 7, article 11, 2007.
- Y. Hu, L. Liao, Q. Wang et al., “Isolation and identification of mesenchymal stem cells from human fetal pancreas,” Journal of Laboratory and Clinical Medicine, vol. 141, no. 5, pp. 342–349, 2003.
- P. S. In 't Anker, W. A. Noort, S. A. Scherjon et al., “Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential,” Haematologica, vol. 88, no. 8, pp. 845–852, 2003.
- Z. Miao, J. Jin, L. Chen et al., “Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells,” Cell Biology International, vol. 30, no. 9, pp. 681–687, 2006.
- T. Nomura, E. Ashihara, K. Tateishi et al., “Therapeutic potential of stem/progenitor cells in human skeletal muscle for cardiovascular regeneration,” Current Stem Cell Research and Therapy, vol. 2, no. 4, pp. 293–300, 2007.
- L. Peng, Z. Jia, X. Yin et al., “Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue,” Stem Cells and Development, vol. 17, no. 4, pp. 761–773, 2008.
- B. C. Perry, D. Zhou, X. Wu et al., “Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use,” Tissue Engineering—Part C, vol. 14, no. 2, pp. 149–156, 2008.
- N. J. Zvaifler, L. Marinova-Mutafchieva, G. Adams et al., “Mesenchymal precursor cells in the blood of normal individuals,” Arthritis Research, vol. 2, no. 6, pp. 477–488, 2000.
- G. La Rocca, R. Anzalone, S. Corrao et al., “Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers,” Histochemistry and Cell Biology, vol. 131, no. 2, pp. 267–282, 2009.
- M. Secco, E. Zucconi, N. M. Vieira et al., “Mesenchymal stem cells from umbilical cord: do not discard the cord!,” Neuromuscular Disorders, vol. 18, no. 1, pp. 17–18, 2008.
- K. Bieback, S. Kern, H. Klüter, and H. Eichler, “Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood,” Stem Cells, vol. 22, no. 4, pp. 625–634, 2004.
- A. Erices, P. Conget, and J. J. Minguell, “Mesenchymal progenitor cells in human umbilical cord blood,” British Journal of Haematology, vol. 109, no. 1, pp. 235–242, 2000.
- S. Kern, H. Eichler, J. Stoeve, H. Klüter, and K. Bieback, “Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue,” Stem Cells, vol. 24, no. 5, pp. 1294–1301, 2006.
- M. L. Weiss, C. Anderson, S. Medicetty et al., “Immune properties of human umbilical cord Wharton's jelly-derived cells,” Stem Cells, vol. 26, no. 11, pp. 2865–2874, 2008.
- K. Sobolewski, A. Małkowski, E. Bańkowski, and S. Jaworski, “Wharton's jelly as a reservoir of peptide growth factors,” Placenta, vol. 26, no. 10, pp. 747–752, 2005.
- L. Eiselleova, K. Matulka, V. Kriz et al., “A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells,” Stem Cells, vol. 27, no. 8, pp. 1847–1857, 2009.
- D. J. Kurz, Y. Hong, E. Trivier et al., “Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 5, pp. 748–754, 2003.
- A. Montero, Y. Okada, M. Tomita et al., “Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation,” The Journal of Clinical Investigation, vol. 105, no. 8, pp. 1085–1093, 2000.
- G. Xiao, D. Jiang, R. Gopalakrishnan, and R. T. Franceschi, “Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2,” The Journal of Biological Chemistry, vol. 277, no. 39, pp. 36181–36187, 2002.
- F. Ng, S. Boucher, S. Koh et al., “PDGF, tgf-2, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (mscs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages,” Blood, vol. 112, no. 2, pp. 295–307, 2008.
- S. Karahuseyinoglu, O. Cinar, E. Kilic et al., “Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys,” Stem Cells, vol. 25, no. 2, pp. 319–331, 2007.
- K. Seshareddy, D. Troyer, and M. L. Weiss, “Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord,” Methods in Cell Biology, vol. 86, pp. 101–119, 2008.
- A. J. Kermani, F. Fathi, and S. J. Mowla, “Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy,” Rejuvenation Research, vol. 11, no. 2, pp. 379–386, 2008.
- H. Klassen, B. Ziaeian, I. I. Kirov, M. J. Young, and P. H. Schwartz, “Isolation of retinal progenitor cells from post-mortem human tissue and comparison with autologous brain progenitors,” Journal of Neuroscience Research, vol. 77, no. 3, pp. 334–343, 2004.
- W.-Y. Park, C.-I. Hwang, C.-N. Im et al., “Identification of radiation-specific responses from gene expression profile,” Oncogene, vol. 21, no. 55, pp. 8521–8528, 2002.
- D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009.
- M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
- L.-L. Lu, Y.-J. Liu, S.-G. Yang et al., “Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials,” Haematologica, vol. 91, no. 8, pp. 1017–1028, 2006.
- R. Sarugaser, D. Lickorish, D. Baksh, M. M. Hosseini, and J. E. Davies, “Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors,” Stem Cells, vol. 23, no. 2, pp. 220–229, 2005.
- P. A. Sotiropoulou, S. A. Perez, M. Salagianni, C. N. Baxevanis, and M. Papamichail, “Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells,” Stem Cells, vol. 24, no. 2, pp. 462–471, 2006.
- P. Kebriaei, L. Isola, E. Bahceci et al., “Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease,” Biology of Blood and Marrow Transplantation, vol. 15, no. 7, pp. 804–811, 2009.
- S. Halfon, N. Abramov, B. Grinblat, and I. Ginis, “Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging,” Stem Cells and Development, vol. 20, no. 1, pp. 53–66, 2011.
- D. Yinze, Q. Ma, F. Cui, and Y. Zhong, “Human umbilical cord mesenchymal stem cells: osteogenesis vivo as seed cells for bone tissue engineering,” Journal of Biomedical Materials Research—Part A, vol. 91, no. 1, pp. 123–131, 2009.
- G. Bianchi, A. Banfi, M. Mastrogiacomo et al., “Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2,” Experimental Cell Research, vol. 287, no. 1, pp. 98–105, 2003.